Liraglutide Truncation-Related Impurity Reference Material
Truncation impurities are relevant to Liraglutide purity profiling and method development.
PARENT PEPTIDE
Liraglutide
MATERIAL TYPE
Sequence-Related Impurity
TARGET PURITY
≥90% (HPLC)
EVIDENCE STATUS
Peer-Reviewed
QUANTITY
DOCUMENTATION
QUALITY CONTEXT
Why This Record Matters
Truncated Liraglutide impurities are well-established in the literature and commercial catalogs. PeptiQore focuses on high-value, underserved variants rather than duplicating existing catalog entries.
POTENTIAL ORIGIN
Premature chain termination during solid-phase synthesis.
Analytical Data Package
PEPTIQORE APPROACH
TRADITIONAL SUPPLIER
Product → CoA
IMPURITY CLASSIFICATION
Sequence-Related ImpurityEVIDENCE STATUS
Peer-ReviewedPARENT PEPTIDE
Liraglutide Quality Hub →RELATED ANALYTICAL MATERIALS
CUSTOM DEVELOPMENT
Can't Find Your Impurity?
PeptiQore supports custom development of peptide-related impurities, sequence variants and degradation materials.